Work

Potential out-of-pocket savings from hematology/oncology drugs for commercially insured patients via Mark Cuban Cost Plus Drug Company.

Year: 2023

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2023.19.11_suppl.22

Authors: Jenny Jing Xiang, Xiudong Lei, Meng Li, Sharon H. Giordano, Ya-Chen Tina Shih, John Kent Lin

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Economic and Financial Impacts of Cancer

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387962157

Cites:

Cited by:

Related to: 10